🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
92.49
+0.54 (0.59%)
At close: Nov 18, 2026, 4:00 PM EST
92.60
+0.11 (0.12%)
After-hours: Nov 18, 2026, 4:32 PM EST

Mirum Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
670.78521.31336.89186.3777.0619.14
Revenue Growth
42.18%54.74%80.76%141.85%302.67%-
Cost of Revenue
122.59100.2481.6447.0412.371.9
Gross Profit
548.19421.07255.25139.3464.6917.24
Selling, General & Admin
340.79257.03202.22145.8889.0759.22
Research & Development
352.48186.18140.63102.61106.84131.43
Operating Expenses
693.27443.21342.85248.49195.91190.65
Operating Income
-145.08-22.14-87.61-109.15-131.22-173.41
Interest Expense
-11.44-14.39-14.31-15.11-15.98-17.59
Interest & Investment Income
15.3612.7313.7913.743.860.37
Currency Exchange Gain (Loss)
-1.20.71.2-1.8--
Other Non Operating Income (Expenses)
-11.421.670.01-1.021.27106.69
EBT Excluding Unusual Items
-153.77-21.43-86.91-113.35-142.07-83.95
Other Unusual Items
4.6---49.08--
Pretax Income
-900.41-21.43-86.91-162.42-142.07-83.95
Income Tax Expense
3.471.941.030.99-6.410.04
Net Income
-903.88-23.36-87.94-163.42-135.67-83.99
Net Income to Common
-903.88-23.36-87.94-163.42-135.67-83.99
Net Income Growth
------
Shares Outstanding (Basic)
605048413430
Shares Outstanding (Diluted)
605048413430
Shares Change
21.24%5.63%16.23%20.31%12.07%20.08%
EPS (Basic)
-15.11-0.47-1.85-4.00-4.01-2.77
EPS (Diluted)
-15.12-0.47-1.85-4.00-4.02-2.77
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-273.8554.879.33-71.05-120.41-132.78
Free Cash Flow Per Share
-4.581.090.20-1.74-3.54-4.38
Gross Margin
81.72%80.77%75.77%74.76%83.94%90.06%
Operating Margin
-21.63%-4.25%-26.00%-58.57%-170.28%-906.12%
Profit Margin
-134.75%-4.48%-26.10%-87.68%-176.05%-438.86%
Free Cash Flow Margin
-40.83%10.53%2.77%-38.12%-156.26%-693.81%
EBITDA
-118.312.11-63.98-98.33-127.98-172.82
EBITDA Margin
-17.64%0.40%-18.99%-52.76%-166.08%-
D&A For EBITDA
26.7724.2423.6310.833.240.6
EBIT
-145.08-22.14-87.61-109.15-131.22-173.41
EBIT Margin
-21.63%-4.25%-26.00%-58.57%-170.28%-
Revenue as Reported
521.31521.31336.89186.3777.0619.14
Advertising Expenses
-10.911.56.349.2
SEC Filings: 10-K · 10-Q